Epitalon EPI

A synthetic peptide developed in Russia, claimed to slow aging and regulate sleep hormones. The evidence behind those claims comes mostly from Russian animal and small observational studies, not from rigorous independent human trials.

Also known as Epithalon, AEDG, Epithalone, Ala-Glu-Asp-Gly, AE-0 peptide, O65P17785G, alanyl-glutamyl-aspartyl-glycine, RefChem:921052

Effects Longevity

Routes Subcutaneous

Legal status Research chemical

WADA Not listed

3D Molecular Structure of C₁₄H₂₂N₄O₉

Drag to rotate · scroll to zoom

Chemistry

Formula: C14H22N4O9
Molar mass: 390.35
CAS: 307297-39-8
PubChem CID: 219042
IUPAC name: (4S)-4-[[(2S)-2-aminopropanoyl]amino]-5-[[(2S)-3-carboxy-1-(carboxymethylamino)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
InChIKey: HGHOBRRUMWJWCU-FXQIFTODSA-N

Reported dosing

Limited data

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 5-10 mg/day

Reported range 5-20 mg/day

Route Subcutaneous injection

Frequency Once daily

Duration 10-20 day course, often repeated a few times per year

Studied mainly in Russian aging research (telomerase/pineal-gland effects); not FDA-approved, and independent Western confirmation is limited.

Where this comes from Russian-language studies; limited independent research

Human data for this compound is limited. Read the figures above as a record of reported use rather than established dosing.